龙津药业(002750) - 2016年9月7日投资者关系活动记录表

Group 1: Company Structure - The largest shareholder is Qunxing Investment, holding 43.82% of the shares [1] - The second largest shareholder is Lixing Industrial, with a stake of 23.60% [1] - Huixinsheng is the third largest shareholder, owning 7.57% [1] Group 2: Business Development - Lixing Industrial has associated enterprises including Panlong Yunhai, Dali Pharmaceutical, and Sanqi Technology [1] - The company is currently focused on traditional Chinese medicine products while monitoring developments in OTC health and major disease prevention sectors [2] - There are no current plans for acquisitions of Panlong Yunhai, but any future developments will be announced promptly [2] Group 3: Product Development - The company is researching oral formulations of Danzhanhua, although current technology limits its bioavailability [2] - Oral formulations are considered more acceptable by doctors and patients due to their convenience and safety [2] - The company does not currently have other OTC products [2]